Oramed Pharmaceuticals
ORMP
#8931
Rank
C$0.13 B
Marketcap
$3.41
Share price
-4.82%
Change (1 day)
7.93%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): C$33.14 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of C$10.23 Million, an increase over its 2022 earnings that were of -C$52.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$33.14 M223.78%
2023 C$10.23 M-119.45%
2022 -C$52.63 Million39.17%
2021 -C$37.82 Million73.93%
2020 -C$21.75 Million18.53%
2019 -C$18.35 Million-16.62%
2018 -C$22 Million38.32%
2017 -C$15.91 Million12.51%
2016 -C$14.14 Million25.01%
2015 -C$11.31 Million18.18%
2014 -C$9.57 Million39.72%
2013 -C$6.85 Million46.4%
2012 -C$4.68 Million128.32%
2011 -C$2.05 Million-51.47%
2010 -C$4.23 Million35.21%
2009 -C$3.13 Million
2007 -C$4.91 Million607.04%
2006 -C$0.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.72 Billion-2,113.66%๐Ÿ‡บ๐Ÿ‡ธ USA
C$25.63 B 72,308.80%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
C$10.64 B 29,960.63%๐Ÿ‡ซ๐Ÿ‡ท France
C$21.72 M-38.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-C$0.32 Billion-978.11%๐Ÿ‡บ๐Ÿ‡ธ USA